1Ryoo J H, Choi J M, Moon S Y, et al. The clinical availabilityof non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-Year's prospective cohort study [ J ]. Atherosclerosis, 2013, 227 ( 2 ) : 398-403.
2Lavine J E, Schwimmer ,1 B, Van Natta M L, et al. Effect of vitamin E or mefformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial[J].Jama, 2011, 305(16) : 1659-1668.
